Basilea reports isavuconazole and ceftobiprole data to be presented at ECCMID
Additionally, posters and oral presentations will feature ceftobiprole, such as data on the activity spectrum of ceftobiprole against current clinical pathogens causing respiratory tract infections and its activity in community- and hospital-acquired ...
GlobeNewswire (press release) - Thu, 23 Apr 2015 22:15



Allergic Fungal Airway Disease: Pathophysiologic and Diagnostic Considerations
Purpose of review Fungal spores are ubiquitously present in indoor and outdoor air. A number can act as aeroallergens in Immunoglobulin E (IgE)-sensitized individuals and some thermotolerant fungi germinate in the lung where they can cause a combined ...
Medscape - Wed, 22 Apr 2015 21:07

Pernix Therapeutics Closes Acquisition of Zohydro ER Franchise
Zohydro ER is contraindicated in patients with significant respiratory depression, acute or severe bronchial asthma, known or suspected paralytic ileus, and hypersensitivity to hydrocodone bitartrate. Zohydro ER has warnings for: interactions with CNS ...
Yahoo Finance UK - Fri, 24 Apr 2015 09:52

POMALYST® (pomalidomide) Label Update Including Progression-Free and ...
Deep venous thrombosis (DVT), pulmonary embolism (PE), myocardial infarction, and stroke occur in patients with multiple myeloma treated with POMALYST. Prophylactic antithrombotic measures were employed in clinical trials. Thromboprophylaxis is ...
Business Wire (press release) - Thu, 23 Apr 2015 14:33



Illicit drug overdose: managing emergency care
Coma, hypotension, bradycardia and respiratory depression occasionally occur but are seldom serious if the drug is taken alone; respiratory depression can be more serious in patients with severe chronic obstructive pulmonary disease. Flumazenil is a ...
The Pharmaceutical Journal - Wed, 22 Apr 2015 07:37

CRESEMBA® (isavuconazonium sulfate) Data to be Presented at the European ...
Serious hypersensitivity and severe skin reactions, such as anaphylaxis or Stevens Johnson syndrome, have been reported during treatment with other azole antifungal agents. Discontinue CRESEMBA if a patient develops a severe cutaneous adverse ...
PR Newswire (press release) - Thu, 23 Apr 2015 07:37

Baxter Supports IPOPI Initiative to Improve Global Care of Primary ...
Patients with antibodies to IgA are potentially at greater risk of developing potentially severe hypersensitivity and anaphylactic reactions. Non-neutralizing antibodies to the recombinant human hyaluronidase component may ... Non-cardiogenic pulmonary ...
PharmiWeb.com (press release) - Tue, 21 Apr 2015 05:56

Egalet Appoints Nicholas Nicolaides, Ph.D. and John Osborn to Board of Directors
OXAYDO is contraindicated in patients with respiratory depression, paralytic ileus, acute or severe bronchial asthma or hypercarbia, or known hypersensitivity to oxycodone or any components of the product. Respiratory depression is the primary risk of ...
PR Newswire (press release) - Mon, 13 Apr 2015 02:56


1  2  3  4  5  6  7  8    ->


We do not evaluate or guarantee the accuracy of any content in this site. Click here for the full disclaimer.

Last update: September 2014